Suven Life Sciences Ltd. - Product Pipeline Review - 2016

  • ID: 3960460
  • Company Profile
  • 38 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • 4SC AG
  • Beactica AB
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Incyte Corporation
  • Oryzon Genomics SA
  • MORE
Suven Life Sciences Ltd. - Product Pipeline Review - 2016

The report ‘Suven Life Sciences Ltd. - Product Pipeline Review - 2016’, provides an overview of the Suven Life Sciences Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Suven Life Sciences Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note - : Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of Suven Life Sciences Ltd.
- The report provides overview of Suven Life Sciences Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Suven Life Sciences Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Suven Life Sciences Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate Suven Life Sciences Ltd.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Suven Life Sciences Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Suven Life Sciences Ltd.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 4SC AG
  • Beactica AB
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Incyte Corporation
  • Oryzon Genomics SA
  • MORE
Introduction

Suven Life Sciences Ltd. Snapshot

Suven Life Sciences Ltd. Overview

Key Facts

Suven Life Sciences Ltd. - Research and Development Overview

Key Therapeutic Areas

Suven Life Sciences Ltd. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Suven Life Sciences Ltd. - Pipeline Products Glance

Suven Life Sciences Ltd. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Suven Life Sciences Ltd. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Suven Life Sciences Ltd. - Drug Profiles

Small Molecule for Psychiatric Disorders - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule to Agonize Cannabinoid Receptor-2 for Pain - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule to Antagonize nAChR Alpha-4 Beta-2 for Pain - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules to Antagonize 5-HT6 Receptors for Cognitive Impairment - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

SUVN-501 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

SUVN-502 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

SUVN-507 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

SUVN-512 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

SUVN-911 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

SUVND-4010 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

SUVNG-3031 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

SUVNI-1307014 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

SUVNI-1312004 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Suven Life Sciences Ltd. - Pipeline Analysis

Suven Life Sciences Ltd. - Pipeline Products by Target

Suven Life Sciences Ltd. - Pipeline Products by Route of Administration

Suven Life Sciences Ltd. - Pipeline Products by Molecule Type

Suven Life Sciences Ltd. - Pipeline Products by Mechanism of Action

Suven Life Sciences Ltd. - Dormant Projects

Suven Life Sciences Ltd. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

List of Tables

Suven Life Sciences Ltd., Key Facts

Suven Life Sciences Ltd. - Pipeline by Indication, 2016

Suven Life Sciences Ltd. - Pipeline by Stage of Development, 2016

Suven Life Sciences Ltd. - Monotherapy Products in Pipeline, 2016

Suven Life Sciences Ltd. - Phase II, 2016

Suven Life Sciences Ltd. - Phase I, 2016

Suven Life Sciences Ltd. - Preclinical, 2016

Suven Life Sciences Ltd. - Pipeline by Target, 2016

Suven Life Sciences Ltd. - Pipeline by Route of Administration, 2016

Suven Life Sciences Ltd. - Pipeline by Molecule Type, 2016

Suven Life Sciences Ltd. - Pipeline Products by Mechanism of Action, 2016

Suven Life Sciences Ltd. - Dormant Developmental Projects,2016

Suven Life Sciences Ltd., Other Locations

Suven Life Sciences Ltd., Subsidiaries

List of Figures

Suven Life Sciences Ltd. - Pipeline by Top 10 Indication, 2016

Suven Life Sciences Ltd. - Pipeline by Stage of Development, 2016

Suven Life Sciences Ltd. - Monotherapy Products in Pipeline, 2016

Suven Life Sciences Ltd. - Pipeline by Target, 2016

Suven Life Sciences Ltd. - Pipeline by Route of Administration, 2016

Suven Life Sciences Ltd. - Pipeline by Molecule Type, 2016

Suven Life Sciences Ltd. - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- 4SC AG
- Beactica AB
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Incyte Corporation
- Oryzon Genomics SA
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll